U.S. federal trademark · Serial No. 98356866
Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence for identification of active immune peptide for treating cancer, infectious and autoimmune diseases.; Research and development in the pharmaceutical and biotechnology fields
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.